Bradley Merrill Thompson Quoted in “FDA Combination Products Design Draft Guidance”

Bloomberg BNA Medical Device Today

Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Bloomberg BNA Medical Device Today, in “FDA Combination Products Design Draft Guidance,” by Michael Williamson.

Following is an excerpt:

“The reason I've been so interested in the combination product human factors guidance is that the issue has been a thorn in industry's side for several years, and we have been urging, no, begging, for this guidance,” Bradley Merrill Thompson, general counsel for the Combination Products Coalition (CPC), an industry group, told Bloomberg BNA in an e-mail. In addition to serving as the CPC's general counsel, Thompson is a Washington-based attorney with Epstein Becker & Green P.C.